Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D is important for skin health and may affect conditions like psoriasis and hair loss, but more research is needed to understand its role fully.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Wnt3a activates certain genes in hair follicle cells, including a newly discovered one, EP2, which may affect hair growth.

Cholesterol transport in hair follicles decreases from growth to regression phase.

Ch55 may help reduce skin scarring and fibrosis.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Stretching skin increases a certain protein that attracts stem cells, helping skin regeneration.

Sema3A can both slow and speed up wound healing, depending on its form and combination with EGF.

PPAR β/δ is important for skin health and disease treatment, but more research is needed.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Piperonylic acid speeds up wound healing by reducing inflammation and boosting collagen.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

Researchers created a 3D-printed skin model that grew human hair when grafted onto mice by improving blood supply to the grafts.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

Erlotinib can cause hair loss as a side effect.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Early regulatory T cells are crucial for normal skin pigmentation.

Skin's epithelial stem cells are crucial for repair and maintenance, and understanding them could improve treatments for skin problems.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Human skin has less GDNF and its receptor with age.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

NFAT5 triggers atherosclerosis under stress by activating inflammation in blood vessels.

EBGS reduces platelet adhesion, potentially helping prevent blood clots.